What is the recommended diagnostic workup and pre‑operative management for an adult with suspected pheochromocytoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pheochromocytoma: Diagnostic Workup and Pre-operative Management

For suspected pheochromocytoma, initiate biochemical testing with plasma free metanephrines or urinary fractionated metanephrines, followed by CT/MRI localization, and begin alpha-blockade for 10-14 days before surgical resection. 1, 2

Diagnostic Workup Algorithm

Step 1: Biochemical Confirmation

  • Measure plasma free metanephrines OR urinary fractionated metanephrines as first-line testing 2
  • For plasma metanephrines: draw blood with patient supine and use position-specific reference intervals 2
  • Use liquid chromatography with mass spectrometry or electrochemical detection methods for optimal accuracy 2
  • All positive results require appropriate follow-up based on the degree of elevation and clinical presentation 2

Key pitfall: False positives occur frequently. More than 4-fold elevation of plasma fractionated metanephrines or elevated 24-hour urinary fractionated metanephrines are diagnostic keys 3. For equivocal results with moderate normetanephrine elevations, perform clonidine suppression testing to differentiate true hypersecretion from false positives 3, 4.

Step 2: Tumor Localization

  • CT is suggested for initial imaging, but MRI is preferred when metastatic disease is suspected or radiation exposure must be limited 2
  • Consider 123I-MIBG scintigraphy for metastatic disease 2

Step 3: Genetic Testing

  • Recommend genetic testing in ALL patients with pheochromocytoma, as 30-40% are hereditary 2, 5, 3
  • Test through accredited laboratories with shared decision-making 2
  • Patients with paraganglioma should specifically be tested for SDHx mutations 2

Pre-operative Management Protocol

Blood Pressure Control (10-14 Days Before Surgery)

Alpha-blockers are first-line agents for patients with severe paroxysmal or sustained hypertension 1:

Medication options:

  • Phenoxybenzamine: 10-20 mg two to three times daily 1
  • Prazosin: 1-3 mg two to three times daily 1
  • Terazosin: 2-10 mg two times daily 1
  • Doxazosin: 2-4 mg two to three times daily 1
  • Alternatives: Alpha-methyldopa or clonidine may also be used 1

Consider adding metyrosine (tyrosine hydroxylase inhibitor): 0.25-1 g four times daily 1

Critical Beta-Blocker Warning

AVOID beta-blockers until adequate alpha blockade is achieved, unless arrhythmias are present 1. Starting beta-blockers first can precipitate unopposed alpha-stimulation and hypertensive crisis.

Volume Expansion

  • High-sodium diet and increased fluid intake during the pre-operative period 2
  • Administer intravenous fluids immediately before surgery to ensure adequate volume expansion and prevent post-resection hypotensive shock 1

Surgical Planning

  • Coordinate with multidisciplinary team: surgical, medical, intensivist, and anesthesia consultants experienced in pheochromocytoma management 1
  • Laparoscopic surgery is preferred over open surgery except for very large tumors 1

Intraoperative Preparation

  • Have phentolamine hydrochloride readily available intravenously for hypertensive crises during surgery 1
  • Intravenous propranolol should be available for arrhythmia treatment 1

Contemporary Controversy

Recent literature (2024-2026) increasingly questions the dogma of routine preoperative alpha-blockade 5, 6. In low-risk patients at experienced centers with strict perioperative monitoring, omission of presurgical treatment may be considered 7, 5. However, given the established safety profile and the Canadian Hypertension Education Program guidelines' clear recommendations, alpha-blockade for 10-14 days remains the standard approach for patients with severe paroxysmal or sustained hypertension to reduce perioperative morbidity and mortality 1.

Additional Considerations

Cardiovascular Evaluation

Perform cardiological assessment to rule out catecholamine-induced cardiomyopathy, myocarditis, or other cardiovascular complications before surgery 4, 8.

Post-operative Follow-up

Lifelong annual follow-up is recommended to detect recurrent or metastatic disease 2, 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.